A 33-year-old woman presents with a sudden-onset 'pins and needles' sensation that…
- User
A 33-year-old woman presents with a sudden-onset 'pins and needles' sensation that started in her feet and is now ascending up her legs. She reports feeling progressively weaker. She had a gastrointestinal illness about two weeks ago. On exam, she has absent deep tendon reflexes. What is the most likely diagnosis? Explain the autoimmune pathophysiology of this disease.
- Assistant
Guillain-Barré Syndrome (GBS)
Explanation of Autoimmune Pathophysiology
GBS is an acute, immune-mediated polyradiculoneuropathy characterized by rapid-onset ascending symmetric weakness and sensory symptoms (e.g., paresthesias), with areflexia due to involvement of peripheral nerves and roots. This patient's history of gastroenteritis (likely Campylobacter jejuni, a common trigger in ~30-50% of cases) 1-3 weeks prior is classic.
The pathophysiology involves molecular mimicry:
- Triggering infection: Pathogens like C. jejuni express lipooligosaccharides (LOS) structurally similar to human peripheral nerve gangliosides (e.g., GM1, GD1a, GQ1b).
- Immune activation: The infection induces a humoral and cellular immune response, producing IgG antibodies against these microbial LOS.
- Cross-reactivity: These antibodies bind to homologous gangliosides on Schwann cells (myelin) and axons in peripheral nerves, targeting motor roots > sensory nerves.
- Effector mechanisms:
- Complement activation: Antibody binding recruits complement, forming the membrane attack complex (MAC), disrupting myelin integrity.
- Macrophage infiltration: Recruited macrophages phagocytose myelin via Fc receptors, leading to segmental demyelination (AIDP variant, most common).
- Direct axonal damage: In severe cases (AMAN/AMSAN variants), antibodies cause axonal degeneration via calcium influx and nodal disruption.
- Result: Conduction block → weakness/areflexia. Symptoms ascend due to length-dependent involvement of longer nerves (legs first).
Diagnosis is clinical + supportive tests (LP: albuminocytologic dissociation; EMG: demyelination). Treatment: IVIG or plasmapheresis to halt antibody-mediated attack. Prognosis: ~80% recover fully, but respiratory failure risk requires monitoring.
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.